Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.

and tumor necrosis factor-a (TNF-a) inhibitors prescribed for other inflammatory conditions such as Crohn’s disease and plaque psoriasis may also lead to GPP in some people. On average ...

Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and ...

Patients with psoriasis treated with tumor necrosis factor inhibitors should adhere to a Mediterranean diet. Patients with melanoma treated with immune checkpoint inhibitors should increase their ...

Coherus BioSciences, Inc.’s CHRS share price has dipped by 5.19%, which has investors questioning if this is right time to ...

Discover a study that assessed the risk of hospitalisation for serious infections based on different categories of systemic ...

Disease activity was followed with Psoriasis Area and Severity Index ... “many patients with joint pain are put on IL-17 blockers or TNF [tumor necrosis factor] blockers, not only IL-23 blockers ...

From plate to pores: How the Mediterranean diet’s transformative power fights stubborn skin disorders—discover the science-backed strategies behind clearer skin and better health. Review ...